Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
425.00    -21.00 (-4.71%)
Bid:
432.50
Ask:
437.00
Spread: 4.50 (1.04%)
Market Cap: £209.02m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

3 Oct 2019 07:00

RNS Number : 5917O
Zotefoams PLC
03 October 2019
 

Zotefoams plc

 

("Zotefoams" or "the Group")

 

Trading Update

 

 

3 October 2019. Zotefoams, a world leader in cellular materials technology, today provides an update on trading.

At the time of our interim results in August we stated that we were mindful of a difficult current trading environment in the European polyolefin foams markets and the less stable political and macroeconomic environment. Since that time the market for polyolefin foams in continental Europe has deteriorated significantly while growth in the North American market has slowed and is now expected to be below our previous estimates.

We anticipate polyolefin foam sales are therefore likely to be around £6 million below current market estimates, resulting in Group sales for the second half of 2019 approximately £2m below the first half of the year. Anticipated profit for this period is impacted by our limited ability to change the operational gearing in the business in this timeframe.

Our High-Performance Products ("HPP") business unit is performing as expected with strong growth in T-FIT® insulation products and ZOTEK® technical foams mainly in aviation and footwear.

Notwithstanding the near-term headwinds in the polyolefin foams business, the Board remains confident in the growth strategy and capacity enhancement investments the Company is making and in the long-term prospects of the business.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

Enquiries:

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

 

Gary McGrath, Group CFO

 

 

 

IFC Advisory (Financial PR & IR)

+44 (0) 203 934 6630

Graham Herring

Zach Cohen

 

 

 

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUGGGWUUPBPGP
Date   Source Headline
21st May 200712:03 pmRNSAnnual Information Update
17th May 20079:14 amRNSDirector/PDMR Shareholding
14th May 20075:55 pmRNSDirectors' Shareholdings
14th May 20073:14 pmRNSResult of AGM
10th May 20077:01 amRNSAGM Statement
19th Apr 20071:47 pmRNSDirector/PDMR Shareholding
13th Apr 20074:31 pmRNSDirector/PDMR Shareholding
12th Apr 20072:34 pmRNSDocuments submission
5th Apr 200712:34 pmRNSBlock Listing Application
20th Mar 20074:18 pmRNSHolding(s) in Company
6th Mar 20077:01 amRNSFinal Results
27th Feb 20072:12 pmRNSHolding(s) in Company
22nd Feb 200710:35 amRNSDirectorate Appointment
18th Dec 20064:58 pmRNSVoting rights & capital
14th Dec 20067:01 amRNSPeriod End Trading Update
5th Dec 20064:50 pmRNSDirector/PDMR Shareholding
17th Nov 20065:00 pmRNSDirector/PDMR Shareholding
13th Oct 20067:00 amRNSDirectorate Change
8th Aug 20067:00 amRNSInterim Results
29th Jun 200611:14 amRNSTrading Statement
15th Jun 20069:56 amRNSBlocklisting Interim Review
23rd May 20062:02 pmRNSResult of AGM
16th May 20067:01 amRNSAGM Statement
11th May 20069:04 amRNSAnnual Information Update
20th Apr 20062:30 pmRNSDirector/PDMR Shareholding
19th Apr 200611:54 amRNSHolding(s) in Company
7th Apr 200612:45 pmRNSAnnual Report and Accounts
30th Mar 20064:14 pmRNSDirectorate Change
29th Mar 200612:27 pmRNSDirector/PDMR Shareholding
29th Mar 200610:49 amRNSDirector/PDMR Shareholding
22nd Mar 20065:14 pmRNSDirector/PDMR Shareholding
21st Mar 20062:37 pmRNSRe Agreement
14th Mar 20067:02 amRNSFinal Results
23rd Dec 200511:24 amRNSDirector/PDMR Shareholding
23rd Dec 200510:19 amRNSDirector/PDMR Shareholding
21st Dec 20055:57 pmRNSHolding(s) in Company
21st Dec 20055:32 pmRNSHolding(s) in Company
15th Dec 20057:00 amRNSPeriod End Trading Update
12th Dec 20054:12 pmRNSBlocklisting Interim Review
22nd Nov 200511:37 amRNSDirector/PDMR Shareholding
2nd Nov 20057:01 amRNSTrading Statement
26th Aug 200512:00 pmRNSUpdate on Directorate
18th Aug 20057:00 amRNSUpdate on Discussions
18th Aug 20057:00 amRNSInterim Results
3rd Aug 200511:23 amRNSRule 8.1- Zotefoams PLC
2nd Aug 200511:14 amRNSRule 8.1- Zotefoams PLC
20th Jul 200511:49 amRNSRule 8.1- Zotefoams PLC
9th Jun 20058:36 amRNSAdditional Listing
3rd May 20055:00 pmRNSHolding(s) in Company
28th Apr 20057:03 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.